MCKESSON CORPMCK
時価総額
$1027.1億
PER
医療サービスと医薬品流通の米国最大手。アウトペイシェント、リテール、スペシャリティ薬局とオンコロジー向けの処方箋技術やデータ解析を展開。2025年3月期に最大顧客向け売上が約24%、2022年11月に処方箋価格透明サービスの同業を100%で買収。米国中心にカナダとノルウェーで展開。
| 2010年 3月31日 | 2011年 3月31日 | 2012年 3月31日 | 2013年 3月31日 | 2014年 3月31日 | 2015年 3月31日 | 2016年 3月31日 | 2017年 3月31日 | 2018年 3月31日 | 2019年 3月31日 | 2020年 3月31日 | 2021年 3月31日 | 2022年 3月31日 | 2023年 3月31日 | 2024年 3月31日 | 2025年 3月31日 | |
| Net income | - | - | - | - | 1,258 | 1,543 | 2,310 | 5,153 | 297 | 255 | 1,120 | -4,340 | 1,287 | 3,722 | 3,160 | 3,481 |
| Depreciation | 148 | 139 | 140 | 146 | 186 | 306 | 281 | 324 | 303 | 317 | 321 | 321 | 279 | 248 | 253 | 242 |
| Amortization | 326 | 357 | 411 | 445 | 518 | 711 | 604 | 586 | 648 | 632 | 601 | 566 | 481 | 360 | 382 | 394 |
| Other Asset Impairment Charges | - | - | - | - | - | - | - | - | - | - | - | - | 175 | 72 | 43 | 98 |
| Deferred taxes | - | - | - | -606 | -16 | -171 | -64 | -882 | 868 | -189 | 342 | 908 | -34 | 20 | 603 | 110 |
| Inventory, LIFO Reserve, Period Charge | - | - | - | - | 311 | 337 | 244 | -7 | -99 | -210 | -252 | -38 | -23 | 1 | -157 | 82 |
| Operating Lease, Expense | - | - | - | - | - | - | - | - | - | - | 366 | 334 | 241 | 249 | 228 | 245 |
| Loss (gain) from sales of businesses and investments | - | - | - | - | - | - | - | - | - | - | -33 | 9 | 132 | 211 | 17 | -485 |
| Provision for bad debts | 17 | 18 | 30 | 28 | - | - | - | - | - | - | - | - | - | - | 819 | -130 |
| Other non-cash items | - | - | -66 | -56 | -130 | -47 | -108 | -88 | 2 | -52 | -615 | -188 | -501 | -298 | -233 | -424 |
| Receivables | -133 | 673 | 770 | -326 | 885 | 2,821 | 1,957 | 762 | -1,175 | 967 | 2,494 | -1,145 | 1,843 | 1,082 | 2,954 | 3,935 |
| Inventories | -782 | -367 | 878 | 59 | 1,201 | 2,144 | 1,251 | -320 | 458 | 368 | 376 | 2,276 | 1,169 | 1,259 | 1,294 | 2,270 |
| Drafts and accounts payable | 1,340 | 533 | 2,027 | -125 | 2,412 | 4,718 | 3,302 | 2,070 | 271 | 1,976 | 3,952 | 1,267 | 2,802 | 3,788 | 4,587 | 8,301 |
| Operating lease liabilities | - | - | - | - | - | - | - | - | - | - | - | - | -356 | -338 | -339 | -404 |
| Taxes | - | - | - | -80 | 218 | -222 | -78 | 146 | 671 | -95 | -8 | -166 | 243 | 363 | 331 | -136 |
| Litigation liabilities | - | - | - | - | - | - | - | - | - | - | - | 8,067 | 199 | -1,088 | -395 | -401 |
| Other | 21 | 144 | 1 | 49 | -86 | -42 | -137 | 365 | -222 | -68 | 8 | -511 | -206 | -56 | -37 | 281 |
| Net cash provided by operating activities | 2,316 | 2,338 | 2,950 | 2,483 | 3,136 | 3,112 | 3,672 | 4,744 | 4,345 | 4,036 | 4,374 | 4,542 | 4,434 | 5,159 | 4,314 | 6,085 |
| Payments for property, plant, and equipment | 199 | 233 | 225 | 246 | 274 | 376 | 488 | 404 | 405 | 426 | 362 | 451 | 388 | 390 | 431 | 537 |
| Capitalized software expenditures | - | - | - | 160 | 141 | 169 | 189 | 158 | 175 | 131 | 144 | 190 | 147 | 168 | 256 | 322 |
| Acquisitions, net of cash, cash equivalents, and restricted cash acquired | 18 | 292 | 1,156 | 1,873 | 4,634 | 170 | 40 | 4,237 | 2,893 | 905 | 133 | 35 | 6 | 867 | 272 | 24 |
| Proceeds from sales of businesses and investments, net | - | - | - | - | - | - | 210 | 206 | - | 101 | - | - | 578 | 1,077 | 47 | 179 |
| Other | -31 | 53 | -89 | -38 | 94 | -23 | 111 | -75 | 18 | 20 | -23 | 139 | 126 | 194 | 160 | 29 |
| Net cash used in investing activities | -309 | -624 | -1,502 | -2,209 | -5,046 | -677 | -1,557 | -3,796 | -1,522 | -1,381 | -579 | -415 | -89 | -542 | -1,072 | -733 |
| Proceeds from Short-Term Debt | 5 | 1,000 | 400 | 2,225 | 6,145 | 3,100 | 1,561 | 8,294 | 20,542 | 37,265 | 21,437 | 6,323 | 11,192 | 8,450 | 19,964 | 15,086 |
| Repayments of short-term borrowings | 6 | -1,000 | - | 2,625 | 6,122 | 3,152 | 1,688 | 8,124 | 20,725 | 37,268 | 21,437 | 6,323 | 11,192 | 8,450 | 19,964 | 15,086 |
| Proceeds from Issuance of Long-Term Debt | - | 1,689 | - | 1,798 | 4,114 | 3 | - | 1,824 | 1,522 | 1,099 | - | 500 | 498 | 997 | 991 | 498 |
| Repayments of long-term debt | 218 | -1,730 | 430 | 1,143 | 356 | 353 | 1,598 | 1,601 | 2,287 | 1,112 | 298 | 1,040 | 1,648 | 1,274 | 288 | 519 |
| Purchase of U.S. government obligations for the satisfaction and discharge of long-term debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 647 | - |
| Issuances | - | - | - | 166 | 177 | 152 | 123 | 120 | 132 | 75 | 113 | 92 | 220 | 163 | 116 | 101 |
| Share repurchases | - | - | 1,874 | 1,214 | 130 | 450 | 1,612 | 2,311 | 1,709 | 1,639 | 1,954 | 770 | 3,516 | 3,638 | 3,025 | 3,146 |
| Dividends paid | - | - | 195 | 194 | 214 | 227 | 244 | 253 | 262 | 292 | 294 | 276 | 277 | 292 | 314 | 345 |
| Other | 40 | 54 | 27 | 31 | 5 | -41 | 5 | -18 | -185 | -355 | -301 | -199 | -383 | -324 | -175 | -554 |
| Net cash used in financing activities | -421 | -1,841 | -1,905 | -956 | 3,619 | -968 | -3,453 | -2,069 | -3,084 | -2,227 | -2,734 | -1,693 | -6,321 | -4,368 | -3,342 | -3,965 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | - | - | - | - | - | - | - | - | - | -119 | -19 | -61 | 55 | 25 | 6 | -16 |
| Cash, cash equivalents, and restricted cash classified as Assets held for sale | - | - | - | - | - | - | - | - | - | - | - | - | -540 | 470 | - | - |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | - | - | - | - | - | - | - | - | - | 309 | 1,042 | 2,373 | -2,461 | 744 | -94 | 1,371 |
| Interest, net | 188 | 244 | 228 | - | - | - | - | - | - | 383 | 235 | 220 | 186 | 224 | 234 | 273 |
| Income Taxes Paid, Net | 234 | 347 | 337 | 55 | 508 | 866 | 923 | 587 | 144 | 262 | 368 | 379 | 359 | 562 | 901 | 1,124 |